Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (191-200 of 460) with videos related to

Pageof 46
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2018
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer EradicationChristopher C Kloss, Jihyun Lee, Aaron Zhang, et al.
Blood|September 18, 2004
Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor functionWayne R Godfrey, Darrin J Spoden, Ying G Ge, et al.
Journal of Immunological Methods|April 7, 2016
Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapyFang Chen, David T Teachey, Edward Pequignot, et al.
Frontiers in Immunology|August 18, 2025
Checkpoint antibody receptor modified ARMed CAR T circumvents the suppressive immunome in GBMDanielle R Cook, Alina C Boesteanu, Yibo Yin, et al.
Journal for Immunotherapy of Cancer|June 4, 2024
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinomaRyan P O'Connell, Kevin Liaw, Nils Wellhausen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010Gregory B Lesinski, William E Carson, Elizabeth A Repasky, et al.
Immunity|July 18, 2002
The CD28 signaling pathway regulates glucose metabolismKenneth A Frauwirth, James L Riley, Marian H Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptorEdmund K Moon, Carmine Carpenito, Jing Sun, et al.
Blood|August 5, 2004
L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejectionPatricia A Taylor, Angela Panoskaltsis-Mortari, Jessica M Swedin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2007
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory moleculesMegan M Suhoski, Tatiana N Golovina, Nicole A Aqui, et al.
Pageof 46

Showing results (191-200 of 460) with videos related to

Sort By:
Pageof 46
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2018
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer EradicationChristopher C Kloss, Jihyun Lee, Aaron Zhang, et al.
Blood|September 18, 2004
Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor functionWayne R Godfrey, Darrin J Spoden, Ying G Ge, et al.
Journal of Immunological Methods|April 7, 2016
Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapyFang Chen, David T Teachey, Edward Pequignot, et al.
Frontiers in Immunology|August 18, 2025
Checkpoint antibody receptor modified ARMed CAR T circumvents the suppressive immunome in GBMDanielle R Cook, Alina C Boesteanu, Yibo Yin, et al.
Journal for Immunotherapy of Cancer|June 4, 2024
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinomaRyan P O'Connell, Kevin Liaw, Nils Wellhausen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010Gregory B Lesinski, William E Carson, Elizabeth A Repasky, et al.
Immunity|July 18, 2002
The CD28 signaling pathway regulates glucose metabolismKenneth A Frauwirth, James L Riley, Marian H Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptorEdmund K Moon, Carmine Carpenito, Jing Sun, et al.
Blood|August 5, 2004
L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejectionPatricia A Taylor, Angela Panoskaltsis-Mortari, Jessica M Swedin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2007
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory moleculesMegan M Suhoski, Tatiana N Golovina, Nicole A Aqui, et al.
Pageof 46